Created: February 25, 2025 • Updated: September 9, 2025
Marcus Lanznar
New York, USA
Marcus Lanznar, a senior executive at Signify Health, faces serious allegations of corporate espionage and misuse of confidential information, as outlined in a federal lawsuit filed by CareCentrix. These claims raise significant concerns about pro...
1.4/5
Trust Score
Composite score based on public data signals and verifiability indicators.
2
Red Flags
The dossier on Marcus Lanznar has been compiled using publicly available sources including court records, regulatory filings, corporate registries, archived media reports, and other verifiable documents. Research is conducted in collaboration with journalists, OSINT analysts, researchers, and citizen contributors.
The information presented is provided for informational and research purposes only and does not constitute legal advice or a legal determination regarding Marcus Lanznar. We welcome credible evidence, corrections, or additional documentation that may help improve the accuracy and completeness of this record.
Marcus Lanznar, a former executive at CareCentrix and current Senior Vice President at Signify Health, has been involved in a high-profile legal dispute concerning allegations of corporate espionage and trade secret theft. These claims have raised serious questions about ethical conduct and legal compliance in the healthcare sector.
Alleged Corporate Espionage
CareCentrix has filed a lawsuit accusing Marcus Lanznar of sharing sensitive business information with Signify Health during his tenure at CareCentrix. The allegations suggest that he provided proprietary data and strategic insights that could give Signify an unfair competitive advantage. This alleged conduct is portrayed as deliberate and coordinated, with potential harm to CareCentrix’s market position.
Violation of Employment Agreements
The lawsuit also contends that Lanznar breached his employment and non-compete agreements by joining Signify Health shortly after leaving CareCentrix. Despite prior assurances that he would not engage with competitors, he allegedly began discussions with Signify while still under CareCentrix’s employment. This raises concerns about adherence to contractual obligations and professional ethics.
Destruction of Evidence
CareCentrix claims that Lanznar destroyed data on his company-issued cellphone on his final day at work. Such actions could eliminate traces of alleged misconduct and complicate investigations. The destruction of evidence raises questions about transparency and accountability in handling sensitive corporate information.
Legal Proceedings and Injunction
A federal judge issued a preliminary injunction preventing Lanznar from working for Signify Health, indicating a strong likelihood of contractual violations. This legal intervention highlights the seriousness of the allegations and potential consequences for both Lanznar and Signify Health. It underscores the legal and regulatory scrutiny surrounding the case.
Public Perception and Reputational Impact
The case has attracted significant media and public attention, with discussions focusing on ethical and legal implications. Such scrutiny has the potential to damage the reputations of both Lanznar and Signify Health, eroding stakeholder trust and public confidence. The controversy illustrates how corporate disputes can have far-reaching reputational consequences.
The allegations against Marcus Lanznar raise substantial concerns regarding corporate ethics, contractual compliance, and protection of sensitive information. The ongoing litigation and media coverage indicate potential reputational risks for all parties involved. Stakeholders should remain vigilant, as the case highlights broader implications for corporate governance and industry standards.
Compliance and Regulatory Intel for Marcus Lanznar
| Risk Category | Assessment Question | Status |
|---|---|---|
| Liabilities | Does have any significant outstanding liabilities that may pose financial risks? | Not Known |
| Undisclosed Relations | Are there undisclosed business relationships or affiliations linked to ? | Possibly Yes |
| Sanctions or Watchlist Matches | Is listed on any international sanctions or compliance watchlists? | Possibly Yes |
| Criminal Record | Does have a record of criminal activity or related investigations? | Possibly Yes |
| Civil Lawsuits | Are there civil lawsuits, past or present, involving ? | Not Known |
| Regulatory Violations | Has faced regulatory violations or penalties? | Not Known |
| Bankruptcy History | Has filed for bankruptcy or been involved in any bankruptcy proceedings? | Definitely Yes |
| Adverse Media Mentions | Have there been significant adverse media mentions related to ? | Not Known |
| Negative Customer Reviews | Are there negative reviews or complaints from customers or clients about ? | Not Known |
| High-Risk Jurisdiction Exposure | Does operate within or have exposure to high-risk jurisdictions? | Possibly Yes |
| Ongoing Investigations | Is currently subject to any ongoing investigations? | Not Known |
| Fraud or Scam Allegations | Have there been fraud or scam allegations involving ? | Not Known |
| Reputational Risk Incidents | Have there been incidents significantly impacting ’s reputation? | Definitely Yes |
| High-Risk Business Activities | Is engaged in any high-risk business activities? | Not Known |
Our Research Methodology for Marcus Lanznar
Sources, verification, and research standards behind our reports.
Public Records Review
LegalObserver analyzes verifiable public records including court filings, regulatory disclosures, enforcement actions, corporate registries, and government databases. Each entry links to original documentation whenever possible to allow independent verification.
Court Filings & Litigation
We examine civil, criminal, and regulatory proceedings involving the subject. This includes lawsuits, judgments, settlements, injunctions, and other documented litigation history obtained from court databases and legal archives.
Corporate & Ownership Data
Corporate filings, director records, shareholder disclosures, and beneficial ownership data are reviewed to identify business affiliations, control structures, and related entities.
Regulatory & Compliance Records
We review enforcement notices, regulatory actions, sanctions listings, compliance warnings, and disciplinary records issued by financial, governmental, and professional authorities.
Media & Archive Research
Coverage from established news organizations, investigative journalism outlets, and archived publications is analyzed to document historical reporting and public narratives associated with the subject.
OSINT Intelligence
Open-source intelligence techniques are used to gather and cross-reference information from publicly accessible sources including corporate registries, official disclosures, archived webpages, and investigative databases.
Censorship & Takedown Monitoring
LegalObserver documents verified attempts to suppress or remove public information, including questionable copyright claims, takedown notices, or legal threats directed at publishers or archives.
Risk & Context Analysis
All verified information is evaluated for context and relevance. The goal is to present documented facts, legal developments, and historical records in a structured format that helps readers understand potential legal, reputational, or compliance risks.
Internet Archives and Screenshots – Marcus Lanznar
About us
- LegalObserver publishes investigative dossiers compiled from publicly available sources including court records, regulatory filings, corporate registries, and archived media reports.
- Our research is conducted in collaboration with journalists, OSINT analysts, researchers, and citizen contributors who review and cross-reference verifiable information.
- We publish information for research and public interest purposes and welcome credible evidence, corrections, or additional documentation that may improve the accuracy of our records.
Source of Information
- 1 telecareaware CareCentrix files ‘corporate espionage’ on trade secrets lawsuit against Signify Health, former employee Retrieved 18/03/2021
- 2 gripeo Marcus Lanznar: Is He a Criminal? Retrieved 27/11/2023
- 3 healthcareitnews CareCentrix files corporate espionage lawsuit against Signify Health Retrieved 17/03/2021
- 4 en.everybodywiki.com Challenges and Controversy at Signify Health Retrieved 09/03/2023
- 5 fiercehealthcare CareCentrix files corporate espionage suit against Signify Health, former exec Retrieved 17/03/2021
Access the Full Intelligence Network
Create a free account to unlock extended dossiers, investigation updates, archive records, and community intelligence. Upgrade for advanced research tools, alerts, and premium investigative reports.
Upgrade to Pro for $10/month
Jon Garnett
Australia
Intel Reports
6
Trust Score
1.8
Ankur Agarwal
Dubai, United Arab Emirates
Intel Reports
1
Trust Score
1.9
User Feedback
Public feedback and intelligence submitted by readers and researchers
1.8
Average Ratings
Based on 8 Ratings
Add Feedback
Your feedback helps improve our platform and service
When a company takes you to federal court, you’re not dealing with a minor dispute. This is serious.
Stealing trade secrets isn’t just shady—it’s a serious breach of trust. Not someone you’d want handling sensitive business information.
Trust is everything in business. If Lanznar misused confidential data, how can anyone trust him in a leadership role?
A lawsuit like this doesn’t just go away. Even if he avoids conviction, his reputation is already damaged.
If someone took your company’s trade secrets and used them against you, you wouldn’t call that “just business.” You’d call it theft.
This case could have long-term consequences for Lanznar and Signify Health. Was it really worth it. and What’s worse stealing trade secrets or getting caught? Either way, it’s a disgrace.
There’s a fine line between competitive strategy and straight-up stealing. Sounds like he crossed it.
High-ranking executives are supposed to set an example, not get caught in legal battles over corporate espionage.